Focal Onset Seizure

Neurology·MeSH: Seizures

6 drugs in development·5 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
fycompa	CATALYST PHARMACEUTICALS, INC. (CPRX)
FYCOMPA®	CATALYST PHARMACEUTICALS, INC. (CPRX)

Phase 3(1)

Drug	Company
xen1101	Xenon Pharmaceuticals Inc. (XENE)

Phase 2(2)

Drug	Company
30mg PRAX-628	Praxis Precision Medicines, Inc. (PRAX)
spn-817	SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Preclinical(1)

Drug	Company
rapport therapeutics product candidate	Neuropace Inc. (NPCE)

BioSniper tracks 6 drugs in development for Focal Onset Seizure across 5 companies.

There are 3 clinical trials targeting Focal Onset Seizure tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.